Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 4, 704–705 (1 September 2005) | doi:10.1038/nrd1839
Acquisitions not a cure for antiinfectives
Abstract
Despite recent purchases, big pharma is still reluctant to return to the field.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
